company background image
PBIO logo

Pressure BioSciences OTCPK:PBIO Stock Report

Last Price

US$0.16

Market Cap

US$4.8m

7D

8.2%

1Y

-88.0%

Updated

26 Mar, 2024

Data

Company Financials

Pressure BioSciences, Inc.

OTCPK:PBIO Stock Report

Market Cap: US$4.8m

PBIO Stock Overview

Pressure BioSciences, Inc. develops and sells pressure-based platform solutions in the North America, Europe, and Asia.

PBIO fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

Pressure BioSciences, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Pressure BioSciences
Historical stock prices
Current Share PriceUS$0.16
52 Week HighUS$1.40
52 Week LowUS$0.14
Beta-0.085
1 Month Change-32.43%
3 Month Change-56.83%
1 Year Change-88.05%
3 Year Change-92.42%
5 Year Change-95.73%
Change since IPO-99.93%

Recent News & Updates

Recent updates

Shareholder Returns

PBIOUS Life SciencesUS Market
7D8.2%-1.9%0.6%
1Y-88.0%3.9%29.5%

Return vs Industry: PBIO underperformed the US Life Sciences industry which returned 3.4% over the past year.

Return vs Market: PBIO underperformed the US Market which returned 29.8% over the past year.

Price Volatility

Is PBIO's price volatile compared to industry and market?
PBIO volatility
PBIO Average Weekly Movement22.5%
Life Sciences Industry Average Movement7.3%
Market Average Movement6.0%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.0%

Stable Share Price: PBIO's share price has been volatile over the past 3 months.

Volatility Over Time: PBIO's weekly volatility (22%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
197817Richard Schumacherhttps://www.pressurebiosciences.com

Pressure BioSciences, Inc. develops and sells pressure-based platform solutions in the North America, Europe, and Asia. The company’s pressure cycling technology (PCT) technology uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control the actions of molecules in biological samples, including cells and tissues from human, animal, plant, and microbial sources. It offers Barocycler instrumentations comprising Barocycler 2320EXT, Barocycler HUB880, Barocycler HUB440, and the Shredder SG3.

Pressure BioSciences, Inc. Fundamentals Summary

How do Pressure BioSciences's earnings and revenue compare to its market cap?
PBIO fundamental statistics
Market capUS$4.81m
Earnings (TTM)-US$29.56m
Revenue (TTM)US$2.27m

2.1x

P/S Ratio

-0.2x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PBIO income statement (TTM)
RevenueUS$2.27m
Cost of RevenueUS$2.12m
Gross ProfitUS$156.61k
Other ExpensesUS$29.71m
Earnings-US$29.56m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.95
Gross Margin6.89%
Net Profit Margin-1,300.58%
Debt/Equity Ratio-73.6%

How did PBIO perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.